Enno Spillner
Director of Finance/CFO at FORMYCON AG
Net worth: 807 244 $ as of 2024-03-30
Network origin in Enno Spillner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Medical Specialties | 21 |
14
| Public Company | Biotechnology | 14 |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France.
14
| Subsidiary | Investment Banks/Brokers | 14 |
12
| Public Company | Pharmaceuticals: Major | 12 |
10
| Public Company | Pharmaceuticals: Major | 10 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program.
4
| Private Company | Investment Managers | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Enno Spillner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| EIFFAGE S.A. | Engineering & Construction | Director/Board Member Director/Board Member Director/Board Member | |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| EURONEXT N.V. | Investment Banks/Brokers | Chief Executive Officer Chief Executive Officer Director/Board Member General Counsel Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Chairman | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chief Executive Officer Chief Executive Officer | |
| Ecole Nationale des Ponts et Chaussées | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Technische Universität München | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Münster | College/University | Masters Business Admin Undergraduate Degree | |
| Institut d'Études Politiques d'Aix-en-Provence | College/University | Undergraduate Degree Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
NYSE Euronext, Inc.
 NYSE Euronext, Inc. Financial ConglomeratesFinance NYSE Euronext operates financial markets and provides trading solutions. It offers an array of products and services in cash equities, futures, options, swaps, exchange-traded products, bonds, clearing operations, market data, commercial technology solutions and carbon trading, all designed to meet the evolving needs of investors, issuers, financial institutions and market participants. The company was founded by Jean-François Théodore in 2007 and is headquartered in New York, NY. | Financial Conglomerates | President Founder Corporate Officer/Principal Corporate Officer/Principal | |
| Ecole Nationale d'Administration | College/University | Undergraduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
ATS Beteiligungsverwaltung GmbH
 ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies. | Investment Managers | Founder Private Equity Investor | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree | |
Federation of European Securities Exchanges
 Federation of European Securities Exchanges Miscellaneous Commercial ServicesCommercial Services The Federation of European Securities Exchanges operates a trade association for financial services. The non-profit company is based in Brussels, Belgium. The CEO of the Belgian company is Rainer Riess. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
Athos Service GmbH
 Athos Service GmbH Financial ConglomeratesFinance Athos Service GmbH operates as an investment company which focuses on the pharmaceutical business. It offers personal investment trust management services. The firm also provides financial advisory services. The company is headquartered in Munich, Germany. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
AT Newtec GmbH
 AT Newtec GmbH Financial ConglomeratesFinance AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
AiCuris GmbH & Co. KG
 AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Jossa Arznei GmbH
 Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Eiffage Group
 Eiffage Group Engineering & ConstructionIndustrial Services Eiffage Group provides construction and civil engineering services. The company was founded in 1990 and is headquartered in Velizy-Villacoublay, France. | Engineering & Construction | Director/Board Member Director/Board Member Director/Board Member | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Paul Ehrlich-Foundation | Chairman Director/Board Member | ||
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| Robert Koch Stiftung eV | Chief Executive Officer Director/Board Member | ||
AT Impf GmbH
 AT Impf GmbH Finance/Rental/LeasingFinance AT Impf GmbH offers purchasing services. It also provides sales and acquisition services. The company was founded on November 12, 2008 and is headquartered in Munich, Germany. | Finance/Rental/Leasing | Chief Executive Officer Corporate Officer/Principal | |
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Institut Supérieur de Gestion | College/University | Graduate Degree Undergraduate Degree | |
| VALNEVA | Biotechnology | Director/Board Member Chairman | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Director/Board Member | |
Momentum Gruppen A/S
 Momentum Gruppen A/S Electric UtilitiesUtilities Momentum Gruppen A/S provides and administrates solar and wind projects. It specializes in procuring, disseminating, and managing solar and wind projects. The firm assists in planning, construction, operational, asset life extension, repowering, decommissioning, and sales and sourcing of projects. The company was founded by Kim Madsen in 2005 and is headquartered in Roskilde, Denmark. | Electric Utilities | Director/Board Member Chairman | |
Dr. Ernst Strüngmann Foundation gGmbH
 Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Eiffage Concessions
 Eiffage Concessions Engineering & ConstructionIndustrial Services Part of Eiffage SA, Eiffage Concessions is a French company that is a leading player in the PPP and Concessions market in France and around the world. The private company is based in Vélizy-Villacoublay, France. The company assists public clients in their project development needs. The company was founded in 1970. Benoît de Ruffray has been the CEO of the company since 2016. | Engineering & Construction | Director/Board Member Director/Board Member Director/Board Member | |
Klinge Pharma GmbH (Bayern)
 Klinge Pharma GmbH (Bayern) Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH is a pharmaceutical company based in Holzkirchen, Germany. Klinge Pharma's mission is to innovate and improve upon traditional pharmaceutical practices. The German company's description emphasizes their commitment to doing things better and their belief that innovation and tradition go hand in hand. The private company was founded in 1933 by A. Klinge and is currently led by CEOs Thomas Strüngmann, Fabian Strüngmann, and Ines Bohn. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder Chairman | |
Momentum Energy Group A/S
 Momentum Energy Group A/S Electric UtilitiesUtilities Momentum Energy Group A/S is a holding Danish company that provides electricity production services. The private company is based in Roskilde, Denmark and has subsidiaries in Denmark. The CEO of the company is Michael Shalmi. | Electric Utilities | Director/Board Member Chief Executive Officer | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Operating Officer |
Statistics
International
| Germany | 28 |
| France | 12 |
| Denmark | 6 |
| United States | 3 |
| Switzerland | 3 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 6 |
| Industrial Services | 4 |
Operational
| Director/Board Member | 446 |
| Corporate Officer/Principal | 182 |
| Chairman | 163 |
| Chief Executive Officer | 125 |
| Independent Dir/Board Member | 46 |
Most connected contacts
| Insiders | |
|---|---|
| Roland Sackers | 78 |
| Helmut Jeggle | 47 |
| Jörg Neermann | 34 |
| Dick M. Sluimers | 32 |
| Hubert Birner | 27 |
| Gerhard Ries | 27 |
| Pascal Oddo | 26 |
| Thomas Werner | 25 |
| Michael Shalmi | 25 |
| Jean-François Roverato | 23 |
| Anne-Marie Graffin | 22 |
| Klaus Röhrig | 22 |
| Wolfgang Plischke | 21 |
| Maïlys Ferrère | 21 |
| Kasim Kutay | 21 |
- Stock Market
- Insiders
- Enno Spillner
- Company connections
